cdaa has been researched along with Carcinogenesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afonso, MB; Cavalluzzi, MM; Gnocchi, D; Ingravallo, G; Lentini, G; Mazzocca, A; Rodrigues, CMP; Sabbà, C | 1 |
| Afonso, MB; Alonso, C; Andersen, JB; Arretxe, E; Banales, JM; Bujanda, L; Castro, RE; Eizaguirre, E; Gaspar, MM; Islam, T; Izquierdo-Sanchez, L; Jimenez-Agüero, R; Lewinska, M; O'Rourke, CJ; Pareja, MJ; Prip-Buus, C; Rodrigues, CMP; Rodrigues, PM; Santos-Laso, Á; Simão, AL | 1 |
2 other study(ies) available for cdaa and Carcinogenesis
| Article | Year |
|---|---|
Inhibition of lysophosphatidic acid receptor 6 upregulated by the choline-deficient l-amino acid-defined diet prevents hepatocarcinogenesis in mice.
Topics: Amino Acids; Animals; Carcinogenesis; Carcinoma, Hepatocellular; Choline; Choline Deficiency; Diet; Liver Neoplasms; Mice; Receptors, Lysophosphatidic Acid | 2023 |
miR-21-5p promotes NASH-related hepatocarcinogenesis.
Topics: Animals; Carcinogenesis; Carcinoma, Hepatocellular; Choline; Liver; Liver Neoplasms; Mice; MicroRNAs; Non-alcoholic Fatty Liver Disease; Obesity; PPAR alpha | 2023 |